| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/09/2008 | EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160312A Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 04/09/2008 | CN101160291A 新颖的hsp90抑制剂 Novel hsp90 inhibitor |
| 04/09/2008 | CN101160139A Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2 |
| 04/09/2008 | CN101157924A Neutrophil leukocyte gene alpha |
| 04/09/2008 | CN101157720A Template fixed peptide analogue as serine protease inhibitor |
| 04/09/2008 | CN101156950A Method of preparing photo-dynamical medicine nanometer magnetic carrier |
| 04/09/2008 | CN101156917A A medicine for preventing and treating livestock birds heat irritability syndrome |
| 04/09/2008 | CN101156888A A traditional Chinese medicine for treating appendicitis |
| 04/09/2008 | CN101156870A A composition for improving growth development and help in improving anamnesis as well as its preparation method |
| 04/09/2008 | CN101156690A Sleep-regulating and anti-senile nutrition health products and method for making same |
| 04/09/2008 | CN101156680A Food composition of nourishing blood anti-senescence and method for producing same |
| 04/09/2008 | CN100379760C Peptides and compounds that bind to receptor |
| 04/09/2008 | CN100379752C Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2008 | CN100379751C Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 04/09/2008 | CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
| 04/09/2008 | CN100379734C Azaindoles |
| 04/09/2008 | CN100379728C Novel imidazole compounds, method for preparing same and use thereof as medicines |
| 04/09/2008 | CN100379723C Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent |
| 04/09/2008 | CN100379722C New compounds |
| 04/09/2008 | CN100379456C Preparation for the prophylaxis of restenosis |
| 04/09/2008 | CN100379449C Compositions of SOD and vetetative medicine or its extractives, and its preparation method |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/09/2008 | CN100379423C Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 04/09/2008 | CN100379416C Stable solid medicinal composition for oral administration. |
| 04/09/2008 | CN100379413C Preparation for improving the action of receptors |
| 04/09/2008 | CN100379348C Method for preparing kidney-warming face-beautifying milk tablet with micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus powder and safflower powder |
| 04/09/2008 | CN100379347C Method for preparing kidney-warming face-beautifying soybean milk tablet with micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus powder and safflower powder |
| 04/08/2008 | US7355081 androgen receptor antagonists; certain cancers, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 04/08/2008 | US7355063 Antioxidants; hyaluronic acid-degrading enzyme inhibitor; water solubility; useful in the fields of foods, medicines, quasi-drugs, cosmetics; analogous to shogaol and gingerol |
| 04/08/2008 | US7355047 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 04/08/2008 | US7355015 Matriptase, a serine protease and its applications |
| 04/08/2008 | US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 04/08/2008 | US7354946 Biarylurea derivatives |
| 04/08/2008 | US7354943 Statine derivatives for the treatment of Alzheimer's disease |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354936 2-phenylpyran-4-one derivatives |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
| 04/08/2008 | US7354910 Agent for treating inflammatory bowel diseases |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | US7354895 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 04/08/2008 | US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists |
| 04/08/2008 | US7354765 Soybean plants with enhanced expression of daidzein and genistein; for use in improving nutrient quality of foods |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354583 Antibody-induced apoptosis |
| 04/08/2008 | US7354577 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
| 04/08/2008 | US7354576 Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase |
| 04/08/2008 | US7353829 Methods and apparatus for multi-photon photo-activation of therapeutic agents |
| 04/08/2008 | CA2337886C Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 04/08/2008 | CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/08/2008 | CA2260315C 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| 04/08/2008 | CA2182504C Process for the preparation of a salt of clavulanic acid |
| 04/08/2008 | CA2169171C New growth/differentiation factor of the tgf-beta family |
| 04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
| 04/03/2008 | WO2008040002A2 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/03/2008 | WO2008039615A2 Controlled release hydrogel formulation |
| 04/03/2008 | WO2008038841A1 Thiadiazolone derivative and use thereof |
| 04/03/2008 | WO2008038768A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 04/03/2008 | WO2008038712A1 Therapeutic/prophylactic agent for metabolic syndrome |
| 04/03/2008 | WO2008038711A1 Oxepin derivative |
| 04/03/2008 | WO2008038705A1 Glycation inhibitor |
| 04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
| 04/03/2008 | WO2008038600A1 1,4-benzodiazepine derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 04/03/2008 | WO2008038599A1 Axonal regeneration promoter |
| 04/03/2008 | WO2008038587A1 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same |
| 04/03/2008 | WO2008038579A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 04/03/2008 | WO2008038423A1 Antiphlogistc and analgetic composition for oral use |
| 04/03/2008 | WO2008038417A1 Cardiovascular preparation |
| 04/03/2008 | WO2007112052A3 Formulations and methods for vascular permeability-related diseases or conditions |
| 04/03/2008 | US20080081841 Materials and Methods for Modulating Cell Motility |
| 04/03/2008 | US20080081838 Inhibition of TNF-alpha-Initiated Neutrophil Response |
| 04/03/2008 | US20080081834 Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders |
| 04/03/2008 | US20080081831 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081821 AZA-benzothiophenyl compounds and methods of use |
| 04/03/2008 | US20080081818 New Piperazine Compound and Use Thereof as a HCV Polymerase Inhibitor |
| 04/03/2008 | US20080081817 7-(3-ethoxybenzyl)-4-[4-[[trans-4-[[N-(2-methoxyethyl)-N-(tert-butyl)amino]methyl]cyclohexyl]carbonyl]piperazin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine; small-conductance calcium activated potassium channel (SK) blocking agent; gastrointestinal, central nervous system disorders, myotonic muscular dystrophy |
| 04/03/2008 | US20080081802 Thiazolyl-Dihydro-Indazole |
| 04/03/2008 | US20080081801 8,13-bisvinyl-2-methyl aminocarbonylethyl-18-(3-(1-imidazolyl)propylamino)carbonyl ethyl-3,7,12,17 tetramethylporphyrin iron complex; albumin clathrate; decreases radiation resistance of hypoxic region of the tumor tissues; highly safe |
| 04/03/2008 | US20080081795 Suppression of nuclear factor-kappaB dependent processes using oligonucleotides |
| 04/03/2008 | US20080081794 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 04/03/2008 | US20080081793 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 04/03/2008 | US20080081791 Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi |
| 04/03/2008 | US20080081787 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 04/03/2008 | US20080081780 Identification of oligoadenylate synthetase-like genes |
| 04/03/2008 | US20080081081 Complement inhibitors; gene expression inhibition of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecular-1 (VCAM-1), and the production of nitric oxide (NO) |
| 04/03/2008 | US20080081069 Novel controlled release formulations of divalproex sodium |
| 04/03/2008 | US20080081064 Drug delivery of two or more drugs (hydrophilic and hydrophobic); arranged within inner space of body member of biodegradable polysaccharide so that each drug in the inner space is individually releasable through their respective aperture set; eye caps |
| 04/03/2008 | US20080081060 Chitosan-coated calcium sulfate based medicament delivery system |
| 04/03/2008 | US20080081053 treating acute myelogenous leukemia (AML) by administering an mTOR inhibitor (mammalian target of rapamycin); rapamycin, temsirolimus (CC1779), everolimus |
| 04/03/2008 | US20080081043 Nucleotide sequences coding natural killer cell ligand for use as tool in treatment cell proliferative disorders |
| 04/03/2008 | CA2664358A1 Diarylketimine derivative |
| 04/03/2008 | CA2664345A1 Oxepin derivative |
| 04/02/2008 | EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905769A1 Heterocycle-substituted benzimidazole derivative |